[
    {
        "Title": "OATP1B3 (699G>A) and CYP2C9*2, *3 significantly influenced the transport and metabolism of glibenclamide and glipizide",
        "Link": "https://www.nature.com/articles/s41598-018-36212-7",
        "Summary": "",
        "Authors": [
            "Fayou Yang",
            "Linlin Liu",
            "Chunhua Xia"
        ],
        "Article Type": "Research",
        "Open Access": "Open Access",
        "Publication Date": "24 Dec 2018",
        "Journal Title": "Scientific Reports",
        "Volume and Pages": "Volume: 8, P: 1-9"
    },
    {
        "Title": "RNAi modulation of placental sFLT1 for the treatment of preeclampsia",
        "Link": "https://www.nature.com/articles/nbt.4297",
        "Summary": "Preeclampsia, a hypertension condition with no approved therapies, is treated in monkeys by gene silencing in the placenta.",
        "Authors": [
            "Anton A Turanov",
            "Agnes Lo",
            "Anastasia Khvorova"
        ],
        "Article Type": "Research",
        "Open Access": "",
        "Publication Date": "19 Nov 2018",
        "Journal Title": "Nature Biotechnology",
        "Volume and Pages": "Volume: 36, P: 1164-1173"
    },
    {
        "Title": "ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis",
        "Link": "https://www.nature.com/articles/s41591-018-0241-1",
        "Summary": "ONECUT2 is a targetable transcription factor that antagonizes androgen receptor signaling and drives androgen independence and neuroendocrine differentiation in castration-resistant prostate cancer.",
        "Authors": [
            "Mirja Rotinen",
            "Sungyong You",
            "Michael R. Freeman"
        ],
        "Article Type": "Research",
        "Open Access": "",
        "Publication Date": "26 Nov 2018",
        "Journal Title": "Nature Medicine",
        "Volume and Pages": "Volume: 24, P: 1887-1898"
    },
    {
        "Title": "Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes",
        "Link": "https://www.nature.com/articles/s41467-018-06936-1",
        "Summary": "Therapeutic alteration of protein expression using modified mRNA is limited by immunogenicity and instability in vivo. Here the authors use antibody-coated lipid nanoparticles to deliver mRNA to leukocytes and drive expression of anti-inflammatory cytokines in an inflammatory bowel disease mouse model.",
        "Authors": [
            "Nuphar Veiga",
            "Meir Goldsmith",
            "Dan Peer"
        ],
        "Article Type": "Research",
        "Open Access": "Open Access",
        "Publication Date": "29 Oct 2018",
        "Journal Title": "Nature Communications",
        "Volume and Pages": "Volume: 9, P: 1-9"
    },
    {
        "Title": "Ligand binding to human prostaglandin E receptor EP4 at the lipid-bilayer interface",
        "Link": "https://www.nature.com/articles/s41589-018-0131-3",
        "Summary": "The structure of human prostaglandin E receptor EP4 in complex with antagonist ONO-AE3-208 and a functional antibody reveals a ligand-binding site at the interface of the lipid bilayer that is unique among GPCRs.",
        "Authors": [
            "Yosuke Toyoda",
            "Kazushi Morimoto",
            "Takuya Kobayashi"
        ],
        "Article Type": "Research",
        "Open Access": "",
        "Publication Date": "03 Dec 2018",
        "Journal Title": "Nature Chemical Biology",
        "Volume and Pages": "Volume: 15, P: 18-26"
    },
    {
        "Title": "A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia",
        "Link": "https://www.nature.com/articles/s41467-018-07684-y",
        "Summary": "The molecular pathway(s) driving antipsychotics (AP) induced hyperphagia remains unclear. A novel C. elegans system is used here to screen for FDA approved drugs that selectively suppresses this response, unraveling potential molecular mediators influencing AP induced hyperphagia in mouse models.",
        "Authors": [
            "Anabel Perez-Gomez",
            "Maria Carretero",
            "Michael Petrascheck"
        ],
        "Article Type": "Research",
        "Open Access": "Open Access",
        "Publication Date": "10 Dec 2018",
        "Journal Title": "Nature Communications",
        "Volume and Pages": "Volume: 9, P: 1-12"
    },
    {
        "Title": "Semisynthesis and antibacterial activities of nidulin derivatives",
        "Link": "https://www.nature.com/articles/s41429-018-0133-0",
        "Summary": "",
        "Authors": [
            "Masahiko Isaka",
            "Arunrat Yangchum",
            "Souwalak Phongpaichit"
        ],
        "Article Type": "Research",
        "Open Access": "",
        "Publication Date": "17 Dec 2018",
        "Journal Title": "The Journal of Antibiotics",
        "Volume and Pages": "Volume: 72, P: 181-184"
    },
    {
        "Title": "Monitoring drug nanocarriers in human blood by near-infrared fluorescence correlation spectroscopy",
        "Link": "https://www.nature.com/articles/s41467-018-07755-0",
        "Summary": "While nanocarrier-based drug delivery is a promising therapeutic approach, in situ characterization of drug nanocarriers in blood remains difficult. Here, the authors demonstrate how the fluorescence correlation spectroscopy can be used to directly characterize drug nanocarriers in flowing blood.",
        "Authors": [
            "Inka Negwer",
            "Andreas Best",
            "Kaloian Koynov"
        ],
        "Article Type": "Research",
        "Open Access": "Open Access",
        "Publication Date": "13 Dec 2018",
        "Journal Title": "Nature Communications",
        "Volume and Pages": "Volume: 9, P: 1-9"
    },
    {
        "Title": "Multidirectional desymmetrization of pluripotent building block en route to diastereoselective synthesis of complex nature-inspired scaffolds",
        "Link": "https://www.nature.com/articles/s41467-018-07521-2",
        "Summary": "Methods enabling the synthesis of diverse collections of nature-inspired compounds with potential medicinal use are sought after in drug design. Here, the authors report a build/couple/pair strategy to efficiently construct chiral polycyclic scaffolds and show their diversification for drug discovery screening.",
        "Authors": [
            "Vunnam Srinivasulu",
            "Paul Schilf",
            "Taleb H. Al-Tel"
        ],
        "Article Type": "Research",
        "Open Access": "Open Access",
        "Publication Date": "26 Nov 2018",
        "Journal Title": "Nature Communications",
        "Volume and Pages": "Volume: 9, P: 1-14"
    },
    {
        "Title": "Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis",
        "Link": "https://www.nature.com/articles/s41467-018-07698-6",
        "Summary": "Activation of PI3K plays a role in pulmonary inflammation. Here, the authors develop a drug inhibitor of PI3K, and show that\u00a0it inhibits lung inflammation and damage in mouse models of asthma and lung fibrosis.",
        "Authors": [
            "Carlo C. Campa",
            "Rangel L. Silva",
            "Emilio Hirsch"
        ],
        "Article Type": "Research",
        "Open Access": "Open Access",
        "Publication Date": "12 Dec 2018",
        "Journal Title": "Nature Communications",
        "Volume and Pages": "Volume: 9, P: 1-16"
    }
]